Related by context. Frequent words. (Click for all words.) 73 Annual Meeting Date 72 FY# Guidance 71 Option Grants 70 Provides Shareholder 70 Regains Compliance 69 Universal Shelf Registration 69 Regains Compliance With 68 Preferred Stock Dividend 68 Shareholder Approval 68 Pomerantz Law Firm 67 Fourth Quarter Dividend 67 Shareholder Letter 67 Shelf Registration Statement 67 NASDAQ Listing 67 2nd Quarter Results 66 Bovie Medical Corporation 66 Patient Enrollment 66 Abraxis trades 66 Share Repurchases 66 FDA Accepts 66 Continued Listing 66 Guidance Quick Facts 66 FDA Clearance 66 Private Placement Offering 66 Record Second Quarter 66 Q1 Loss Narrows 66 Q2 Loss Narrows 65 Record Third Quarter 65 Merger Transaction 65 Shelf Registration 65 Statutory Basis 65 PLEASE REFER TO 65 Private Placement Financing 65 BY MARK FARINELLA 65 Q3 Loss Narrows 65 Forecast Quick Facts 65 Offering Quick Facts 65 Stock Repurchase Plan 65 Explore Strategic Alternatives 65 BY PETER GOBIS 65 Updates Guidance 64 Guides Q3 64 3rd Quarter Results 64 Common Share Offering 64 Q2 Loss Widens 64 Preliminary Third Quarter 64 Guides Q4 64 Grants Options 64 M d yyyy 64 Flow Through Financing 64 Files Shelf Registration Statement 64 Share Buyback Program 64 BY JIM HAND 64 Over Allotment 64 Previously Announced 64 Shareholder Lawsuit 64 Announces Dismissal 64 Stock Profiler.US 64 #:#-# Abstract Free [009] 64 Declares Distribution 64 1st Quarter Results 64 Workforce Reduction 63 Stockholder Rights Plan 63 Final Tranche 63 Record Fourth Quarter 63 Reaffirms Guidance 63 Completes Tender Offer 63 BY AMY DeMELIA 63 Director Shareholding 63 #:#-# Abstract Free [006] 63 Common Share Dividend 63 free E Newsletters 63 Q4 Loss Widens 63 Debt Tender Offer 63 Extends Tender Offer 63 Guides Q2 63 Print Issue 63 -leukemias 63 StockSource.us Reports 63 Announces Stockholder Approval 63 By Jose Vilches 63 BY STEPHEN PETERSON 63 HAS BEEN PREPARED BY 63 Schedules Fiscal 63 IIROC Resume 63 Q3 Loss Widens 63 BY DAVID LINTON 63 Closes Private Placement 63 MAY CONTAIN FORWARD LOOKING 63 #.#/Share [002] 63 #:#-# Abstract Free [008] 63 Share Repurchase Plan 63 BY RYAN ERNST 63 Regulatory Disclosure 62 Anika Therapeutics 62 #:#-# Abstract Free [005] 62 Preliminary Approval 62 Monthly Distributions 62 Announces FDA Clearance 62 Transcept Pharmaceuticals 62 Provides Updates